Evidence map›Paper›PMID 42003798›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

A 3D In Vitro Model of the Human Hepatobiliary Junction.

Ashley D Westerfield, Katarzyna A Grzelak, Katie Katsuyama, Vardhman Kumar, Bess M Miller, Joa Yun, Jesse Kirkpatrick, David Mankus, Margaret E Bisher, Abigail K R Lytton-Jean and 4 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Ashley D WesterfieldInstitute of Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.ORCID https://orcid.org/0000-0001-9665-3548
Katarzyna A GrzelakInstitute of Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.ORCID https://orcid.org/0009-0005-1086-4608
Katie KatsuyamaDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Vardhman KumarDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.ORCID https://orcid.org/0000-0002-1280-2161
Bess M MillerDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Joa YunDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Jesse KirkpatrickInstitute of Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
David MankusDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Margaret E BisherDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Abigail K R Lytton-JeanDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Z Gordon JiangDepartment of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
David D LeeDepartment of Surgery, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Christopher S ChenDepartment of Biomedical Engineering and the Biological Design Center, Boston University, Boston, Massachusetts, USA.
Sangeeta N BhatiaInstitute of Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.ORCID https://orcid.org/0000-0002-1293-2097

Funding

VIRUS PRODUCTION COREP30CA014051 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Jacqueline A. Lees · 1985 to 2026
$93.9M
Cholesterol toxicity in alcohol-associated hepatitisR01AA030770 · NIAAA · BETH ISRAEL DEACONESS MEDICAL CENTER · PI Zhenghui Gordon Jiang · 2023 to 2026
$2.7M
Synthetic vascularization and regeneration in engineered tissuesR01EB033821 · NIBIB · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI SANGEETA N. BHATIA, CHRISTOPHER S CHEN · 2023 to 2026
$2.2M
NCI NIH HHS P30 CA014051NCI NIH HHS P30-CA14051NIAA R01AA030770NIAAA NIH HHS R01 AA030770NIBIB NIH HHS R01 EB033821NIH HHS DGE-1656518NIH HHS EB033821NSF DGE-1656518NSF EB033821Wellcome Leap HOPE ProgramWellcome Trust
6 · The paper itself

Abstract

Bile flow is an essential feature of the liver, and disruption of this process contributes to a range of liver pathologies. Efficient bile transport requires coordinated organization between hepatocytes and cholangiocytes at the hepatobiliary junction, a structure that remains poorly captured in existing in vitro models of liver disease. Here, we present a 3D multicellular spheroid-based model of the human hepatobiliary junction. Building on advances in organoid and spheroid engineering, we co-aggregate human hepatocytes and intrahepatic cholangiocytes, supported by murine fibroblasts, into adult hepatobiliary organoids (aHBOs). aHBOs directionally transport bile from hepatocyte canaliculi to cholangiocyte-lined ductule-like structures, visualized through a high-throughput imaging assay. Hepatobiliary junction formation and bile flow dynamics are quantified over time using a fluorescent bile acid analog and AI-assisted image analysis. When subjected to hypoxia-reoxygenation, aHBOs exhibit disrupted bile transport and distinct cell-type-specific responses, enabling interrogation of hepatocyte and cholangiocyte vulnerability to transplant-associated biliary hypoxia. Our findings suggest a reversible reduction in hepatocyte canalicular function under hypoxia, followed by selective cholangiocyte death upon reoxygenation, potentially contributing to biliary dysfunction after ischemic injury. This human-derived, scalable platform provides a phenotypically relevant model for dissecting mechanisms of biliary dysfunction and discovering therapeutics for hypoxic liver injury and cholestatic diseases.

Indexed as

BileBile DuctsHepatocytesLiverOrganoidsAnimalsHumansMiceMicrophysiological SystemsSpheroids, Cellularbilebile duct engineeringhepatobiliary organoidliver tissue engineeringorganoid

Identifiers

PMID42003798
PMCPMC13334853

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.